310 related articles for article (PubMed ID: 25802215)
1. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Praet J; Orije J; Kara F; Guglielmetti C; Santermans E; Daans J; Hens N; Verhoye M; Berneman Z; Ponsaerts P; Van der Linden A
NMR Biomed; 2015 Apr; 28(4):505-13. PubMed ID: 25802215
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.
Le Blon D; Guglielmetti C; Hoornaert C; Quarta A; Daans J; Dooley D; Lemmens E; Praet J; De Vocht N; Reekmans K; Santermans E; Hens N; Goossens H; Verhoye M; Van der Linden A; Berneman Z; Hendrix S; Ponsaerts P
J Neuroinflammation; 2016 Nov; 13(1):288. PubMed ID: 27829467
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Orije J; Kara F; Guglielmetti C; Praet J; Van der Linden A; Ponsaerts P; Verhoye M
Neuroimage; 2015 Jul; 114():128-35. PubMed ID: 25871629
[TBL] [Abstract][Full Text] [Related]
4. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
[TBL] [Abstract][Full Text] [Related]
5. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
6. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
7. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
[TBL] [Abstract][Full Text] [Related]
8. Demyelination of the hippocampus is prominent in the cuprizone model.
Koutsoudaki PN; Skripuletz T; Gudi V; Moharregh-Khiabani D; Hildebrandt H; Trebst C; Stangel M
Neurosci Lett; 2009 Feb; 451(1):83-8. PubMed ID: 19084049
[TBL] [Abstract][Full Text] [Related]
9. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.
Janssen K; Rickert M; Clarner T; Beyer C; Kipp M
Mol Neurobiol; 2016 Apr; 53(3):1551-1564. PubMed ID: 25663168
[TBL] [Abstract][Full Text] [Related]
10. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
11. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
[TBL] [Abstract][Full Text] [Related]
13. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss.
Doan V; Kleindienst AM; McMahon EJ; Long BR; Matsushima GK; Taylor LC
J Neurosci Res; 2013 Mar; 91(3):363-73. PubMed ID: 23280518
[TBL] [Abstract][Full Text] [Related]
14. TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Sághy É; Sipos É; Ács P; Bölcskei K; Pohóczky K; Kemény Á; Sándor Z; Szőke É; Sétáló G; Komoly S; Pintér E
Glia; 2016 Dec; 64(12):2166-2180. PubMed ID: 27568827
[TBL] [Abstract][Full Text] [Related]
15. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI.
Boretius S; Escher A; Dallenga T; Wrzos C; Tammer R; Brück W; Nessler S; Frahm J; Stadelmann C
Neuroimage; 2012 Feb; 59(3):2678-88. PubMed ID: 21914485
[TBL] [Abstract][Full Text] [Related]
16. Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.
Liu J; Tian D; Murugan M; Eyo UB; Dreyfus CF; Wang W; Wu LJ
J Neurochem; 2015 Oct; 135(2):347-56. PubMed ID: 26173779
[TBL] [Abstract][Full Text] [Related]
17. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
18. Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Fjær S; Bø L; Lundervold A; Myhr KM; Pavlin T; Torkildsen O; Wergeland S
PLoS One; 2013; 8(12):e84162. PubMed ID: 24386344
[TBL] [Abstract][Full Text] [Related]
19. The cuprizone-induced changes in (1)H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine.
Xuan Y; Yan G; Wu R; Huang Q; Li X; Xu H
Neurochem Int; 2015 Nov; 90():185-92. PubMed ID: 26340869
[TBL] [Abstract][Full Text] [Related]
20. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
